Therefore, this study confirms the potential use of increased IFN‐γ levels posttreatment as a correlate of response to IL‐12 gene therapy and the potential importance of increased CD4+ and TIA‐1+ CD8+ T cell tumor infiltration. The gene discussed is IFNG; the disease is neoplasm.